Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy.

Matteo RuggeriFederica RomanoMichele BasileSilvia CorettiFrancesca Romana RolliCarlo DragoAmerico Cicchetti

Published in: Applied health economics and health policy (2019)

Extending the treatment of HCV to patients at an early stage of HCV infection is estimated to be cost effective from the perspective of the Italian Healthcare System.

Keyphrases

hepatitis c virus
early stage
human immunodeficiency virus
radiation therapy
lymph node
neoadjuvant chemotherapy